These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34653686)

  • 1. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
    Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
    Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults.
    Hua S; Qi Q; Kizer JR; Williams-Nguyen J; Strickler HD; Thyagarajan B; Daviglus M; Talavera GA; Schneiderman N; Cotler SJ; Cai J; Kaplan R; Isasi CR
    Diabet Med; 2021 Aug; 38(8):e14522. PubMed ID: 33434318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.
    Liu X; Hamnvik OP; Chamberland JP; Petrou M; Gong H; Christophi CA; Christiani DC; Kales SN; Mantzoros CS
    Metabolism; 2014 Jun; 63(6):773-82. PubMed ID: 24726813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
    Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Watanabe A; Sakamoto K; Kokaze A
    BMC Nephrol; 2020 Nov; 21(1):471. PubMed ID: 33172399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased liver markers are associated with higher risk of type 2 diabetes.
    Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
    World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple health behaviors and serum hepatic enzymes among US adults with obesity.
    Tsai J; Ford ES; Zhao G; Croft JB
    Prev Med; 2011 Oct; 53(4-5):278-83. PubMed ID: 21893086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
    Lazo M; Rubin J; Clark JM; Coresh J; Schneider AL; Ndumele C; Hoogeveen RC; Ballantyne CM; Selvin E
    J Hepatol; 2015 Apr; 62(4):841-7. PubMed ID: 25433159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality.
    Arndt V; Brenner H; Rothenbacher D; Zschenderlein B; Fraisse E; Fliedner TM
    Int Arch Occup Environ Health; 1998 Sep; 71(6):405-12. PubMed ID: 9766914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.
    Tsai J; Ford ES; Zhao G; Li C; Greenlund KJ; Croft JB
    J Behav Med; 2012 Apr; 35(2):200-10. PubMed ID: 21626151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010.
    Lee K; Yang JH
    Metab Syndr Relat Disord; 2013 Aug; 11(4):229-35. PubMed ID: 23451816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP).
    Markus MR; Meffert PJ; Baumeister SE; Lieb W; Siewert U; Schipf S; Koch M; Kors JA; Felix SB; Dörr M; Targher G; Völzke H
    Atherosclerosis; 2016 Feb; 245():123-31. PubMed ID: 26722832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
    Schneider AL; Lazo M; Ndumele CE; Pankow JS; Coresh J; Clark JM; Selvin E
    Diabet Med; 2013 Aug; 30(8):926-33. PubMed ID: 23510198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults.
    Tsai J; Ford ES; Li C; Zhao G
    Addict Behav; 2012 Jan; 37(1):78-84. PubMed ID: 21975024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.
    Marchesini G; Avagnina S; Barantani EG; Ciccarone AM; Corica F; Dall'Aglio E; Dalle Grave R; Morpurgo PS; Tomasi F; Vitacolonna E
    J Endocrinol Invest; 2005 Apr; 28(4):333-9. PubMed ID: 15966506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.
    Xuan Y; Wu D; Zhang Q; Yu Z; Yu J; Zhou D
    Front Endocrinol (Lausanne); 2024; 15():1457598. PubMed ID: 39253584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.
    Khedmat H; Fallahian F; Abolghasemi H; Hajibeigi B; Attarchi Z; Alaeddini F; Holisaz MT; Pourali M; Sharifi S; Zarei N
    World J Gastroenterol; 2007 Feb; 13(6):889-94. PubMed ID: 17352018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
    Whitfield JB; Zhu G; Madden PAF; Montgomery GW; Heath AC; Martin NG
    Alcohol Clin Exp Res; 2019 Mar; 43(3):473-482. PubMed ID: 30589442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study.
    Ceriotti F; Henny J; Queraltó J; Ziyu S; Özarda Y; Chen B; Boyd JC; Panteghini M; ;
    Clin Chem Lab Med; 2010 Nov; 48(11):1593-601. PubMed ID: 21034260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.